Stock ARIAD PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Ariad Pharmaceuticals, Inc.

Equities

US04033A1007

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Ariad Pharmaceuticals, Inc.
2017 Takeda Pharmaceutical : Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal RE
2014 Dai ichi Life Insurance : U.S. futures flat with Dow, S&P at record levels RE

Managers

Managers TitleAgeSince
Teresa Bitetti PSD
 President - -
Tetsu Inada BRD
 Director/Board Member - -
Jason E. Baranski SEC
 Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Teresa Bitetti PSD
 President - -
Tetsu Inada BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 194,200,862 187,644,037 ( 96.62 %) 0 96.62 %

Company contact information

ARIAD Pharmaceuticals, Inc.

40 Landsdowne Street

02139, Cambridge

+617-494-0400

http://www.ariad.com
address Ariad Pharmaceuticals, Inc.

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-3.30% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.79% 96.07B
ARGENX SE Stock argenx SE
-0.44% 21.66B
BIONTECH SE Stock BioNTech SE
-18.35% 20.77B
GENMAB A/S Stock Genmab A/S
-7.45% 18.53B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-40.31% 16.91B
BEIGENE, LTD. Stock BeiGene, Ltd.
-26.84% 13.79B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+0.59% 13.33B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+20.86% 10.94B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Ariad Pharmaceuticals, Inc.